Moody Aldrich Partners’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.12M | Sell |
95,435
-1,480
| -2% | -$63.9K | 0.8% | 61 |
|
|
2025
Q1 | $3.35M | Sell |
96,915
-2,769
| -3% | -$95.7K | 0.7% | 60 |
|
|
2024
Q4 | $2.74M | Sell |
99,684
-23,825
| -19% | -$654K | 0.51% | 78 |
|
|
2024
Q3 | $3.14M | Sell |
123,509
-2,320
| -2% | -$59.1K | 0.57% | 76 |
|
|
2024
Q2 | $3.19M | Sell |
125,829
-23,393
| -16% | -$593K | 0.62% | 77 |
|
|
2024
Q1 | $4.61M | Buy |
149,222
+24,238
| +19% | +$749K | 0.78% | 55 |
|
|
2023
Q4 | $5.05M | Sell |
124,984
-12,528
| -9% | -$506K | 0.91% | 45 |
|
|
2023
Q3 | $3.63M | Buy |
137,512
+57,639
| +72% | +$1.52M | 0.69% | 63 |
|
|
2023
Q2 | $1.37M | Sell |
79,873
-64,980
| -45% | -$1.12M | 0.27% | 105 |
|
|
2023
Q1 | $2.4M | Buy |
+144,853
| New | +$2.4M | 0.48% | 80 |
|